Korean J Hematol.  2007 Dec;42(4):343-352. 10.5045/kjh.2007.42.4.343.

Risk Factors of Bloodstream Infection Associated Mortality in Pediatric Patients with Hemato-oncologic Disease

• Park HW
• Youn HS
• Im HJ
• Kim MN
• Seo JJ
• Moon HN

• KMID: 2252219
• DOI: http://doi.org/10.5045/kjh.2007.42.4.343

Abstract

BACKGROUND: Bloodstream infection is one of the important causes of mortality, and morbidity in pediatric patients with hemato-oncologic disease. The purpose of this study was to identify the risk factors related to mortality in patients who suffered from a bloodstream infection.
METHODS
We retrospectively reviewed and analyzed the medical records of 133 pediatric patients with hemato-oncologic diseases who had episodes of bloodstream infection documented at Asan Medical Center from June 2002 through May 2005.
RESULTS
A total of 288 pathogens were isolated, and there were 17 episodes of polymicrobial infections. Among the episodes of bloodstream infection, 93.4% were caused by bacteria of which 60.1% were gram-positive bacteria, and 33.3% were gram-negative bacteria. Fungal infections accounted for 6.6% of the infections. The main pathogens included Staphylococcus epidermidis (31.3%), Pseudomonas aeruginosa (8.3%), and Klebsiella pneumoniae (7.3%). Gram-positive organisms were isolated more frequently than gram-negative organisms, and non-albicans Candida species were documented more frequently than C. albicans in our study. Infection related mortality was 8.3% (11 of 133 patients). The pulmonary infiltration on chest X-ray (CXR) (P=0.001), and a low absolute neutrophil count (< or = 500/micorL) (P=0.017) at the time of blood culture were significantly associated with mortality. Gram-negative bacterial infection (especially with Stenotrophomonas maltophilia) and fungal infection often progressed to the septic shock or death.
CONCLUSION
This study revealed that the presence of pulmonary infiltration on a CXR, neutropenia (< or = 500/microL), and gram-negative bacterial infection might be important risk factors of mortality in pediatric patients with hemato-oncologic diseases necessitating more aggressive and vigilant supportive care.

Keyword

Bloodstream infection; Childhood cancer; Risk factors; Mortality

MeSH Terms

Bacteria
Candida
Chungcheongnam-do
Coinfection
Gram-Negative Bacteria
Gram-Negative Bacterial Infections
Gram-Positive Bacteria
Humans
Klebsiella pneumoniae
Medical Records
Mortality*
Neutropenia
Neutrophils
Pseudomonas aeruginosa
Retrospective Studies
Risk Factors*
Shock, Septic
Staphylococcus epidermidis
Stenotrophomonas
Thorax

Reference

1). Krupova I., Kaiserova E., Foltinova A, et al. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome. J Chemother. 1988. 10:236–42.

2). Hann I., Viscoli C., Paesmans M., Gaya H., Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: result from four EORTC studies. Br J Haematol. 1997. 99:580–8.

3). Alexander S., Walsh T., Freifeld A., Pizzo P. Infectious complications in pediatric cancer patients. Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th ed.Philadelphia: Lippincott Williams and Wilkins;2002. p. 1239–83.

4). Pizzo PA. Evaluation of fever in the patient with cancer. Eur J Cancer Clin Oncol. 1989. 25:9–16.

5). McCullers J., Shenep J. Assessment and management of suspected infection in neutropenic patients. Patrick C, editor. Clinical management of infections in immunocompromised infants and children. 1st ed.Philadelphia: Lippincott Williams and Wilkins;2001. p. 413–49.

6). Hughes WT., Armstrong D., Bodey GP, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. In-fections diseases society of America. Clin Infect Dis. 1997. 25:551–73.

7). Weinstein MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis. 1996. 23:40–6.

8). El-Mahallawy H., Sidhom I., El-Din NH., Zamzam M., El-Lamie MM. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study. Int J Infect Dis. 2005. 9:43–51.

9). Velasco E., Thuler LC., Martins CA., Dias LM., Goncalves VM. Risk factors for bloodstream infections at a cancer center. Eur J Clin Microbiol Infect Dis. 1998. 17:587–90.

10). Viscoli C., Castagnola E., Giacchino M, et al. Bloodstream infections in children with cancer: a multi-centre surveillance study of the Italian association of pediatric hematology and oncology. Supportive therapy group-infectious disease section. Eur J Cancer. 1999. 35:770–4.

11). Cho SM., Lee DG., Choi JM., Yoo JH., Sin WS., Kim CC. Septic shock in hematology oncology patients with neutropenic fever. Int J Infectious Dis. 2002. 6:531–2.

12). Apisarnthanarak A., Mayfield JL., Garison T, et al. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol. 2003. 24:269–74.

13). Velasco E., Byington R., Martins CS., Schirmer M., Dias LC., Goncalves VM. Bloodstream infection surveillance in cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect. 2004. 10:542–9.

14). Wu PS., Lu CY., Chang LY, et al. Stenotrophomonas maltophilia bacteremia in pediatric patients-a 10-year analysis. J Microbiol Immunol Infect. 2006. 39:144–9.

15). Abi-Said D., Anaissie E., Uzun O., Raad I., Pinzcowski H., Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997. 24:1122–8.

16). Simoneau E., Kelly M., Labbe AC., Roy J., Laverdiere M. What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant. 2005. 36:85–6.

17). Kami M., Murashiqe N., Fujihara T., Sakagami N., Tanaka Y. The mechanism for low yield of blood culture in invasive aspergillosis; the clinical importance of antigen detection tests revisited. Bone Marrow Transplant. 2005. 35:303–6.

18). Velasco E., Thuler LC., Martins CA., Nucci M,?Dias LM., Goncalves VM. Epidemiology of bloodstream infections at a cancer center. Sao Paulo Med J. 2000. 118:131–8.

19). Tsiotou AG., Sakorafas GH., Anagnostopoulos G., Bramis J. Septic shock; Current pathogenic concepts from a clinical perspective. Med Sci Monit. 2005. 11:RA76–85.

20). Kutko MC., Calarco MP., Flaherty MB, et al. Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med. 2003. 4:333–7.

21). Black CT., Hennessey PJ., Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma. 1990. 30:830–2.

22). Palmblad J. Intravenous lipid emulsions and host defense- a critical review. Clin Nutr. 1991. 10:303–8.

23). Shou J., Lappin J., Minnard EA., Daly JM. Total parenteral nutrition, bacterial translocation, and host immune function. Am J Surg. 1994. 167:145–50.

24). Stoll BJ., Temprosa M., Tyson JE, et al. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics. 1999. 104:63.

25). Barsic B., Beus I., Marton E., Himbele J., Klinar I. Nosocomial infections in critically ill infectious disease patients: results of a 7-year focal surveillance. Infection. 1999. 27:16–22.